MR thèse 2006-21 - Bibliothèque Ecole Centrale Lyon

More documents

Recommendations

Info

Chapitre I – Les ATNC, un problème de Santé Publique ENARI, M., FLECHSIG, E. and WEISSMANN, C. (2001). Scrapie prion protein accumulation by scrapieinfected neuroblastoma cells abrogated by exposure to a prion protein antibody. Proceedings of the National Academy of Sciences. 98: 9285-9299 HEEG, P. (2004). Reprocessing endoscopes: national recommendations with a special emphasis on cleaning--the German perspective. Journal of Hospital Infection. 56 Suppl 2: S23-6 LASMEZAS, C.I., DESLYS, J.-P., DEMAIMAY, R., ADJOU, K.T., LAMOURY, F., DORMOND, D., ROBAIN, O., IRONSIDE, J.W. and HAUW, J.J. (1996). BSE transmission to macaques. Nature. 381: 743-744 LAVOUE, J., BEGIN, D. and GERIN, M. La substitution des solvants par les nettoyants aqueux: le dégraissage des métaux (2002) Université de Montréal LEGNAME, G., BASKAKOV, I.V., NGUYEN, H.O., RIESNER, D., COHEN, F.E., DEARMOND, S.J. and PRUSINER, S.B. (2004). Synthetic mammalian prions. Science. 305: 673-676 LLEWELYN, C.A., HEWITT, P.E., KNIGHT, R.S.G., AMAR, K., COUSENS, S., MACKENZIE, J. and WILL, R.G. (2004). Possinle transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet. 363: 417-421 MERZ, P.A., SOMERVILLE, R.A., WISNIEWSKI, H.M. and IQBAL, K. (1981). Abnormal fibrils from scrapie-infected brain. Acta Neuropathologica. 54: 63-74 OESCH, B., WESTAWAY, D., WALCHLI, M., MCKINLEY, M.P., KENT, S.B., AEBERSOLD, R., BARRY, R.A., TEMPST, P., TEPLOW, D.B. and HOOD, L. (1985). A cellular gene encodes scrapie PrP27-30 protein. Cell. 40: 735-746 PADILLA, A. WHO Consultation on tissue infectivity distribution in Transmissible Spongiform Encephalopathies (2005) 14-16 septembre Genève, Suisse PAN, K.M., BALDWIN, M.A., NGUYEN, J., GASSET, M., SERBAN, A., GROTH, D., MELHORN, I., HUANG, Z., FLETTERICK, R.J., COHEN, F.E. and PRUSINER, S.B. (1993). Conversion of α-helices into β-sheets features in the formation of the scrapie prion proteins. Proceedings of the National Academy of Sciences. 90: 10962-10966 PARCHI, P., GIESE, A., CAPELLARI, S., BROWN, P., SCHULZ-SCHAEFFER, W.J., WINDL, O., ZERR, I., BUDKA, H., KOPP, N., PICCARDO, P., POSER, S., ROJIANI, A., STREICHENBERGER, N., JULIEN, J., VITAL, C., GHETTI, B., GAMBETTI, P. and KRETZSCHMAR, H.A. (1999). Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 200 subjects. Annals of Neurology. 46: PARCHI, P., ZOU, W., WANG, W., BROWN, P., CAPELLARI, S., GHETTI, B., KOPP, N., SCHULZ- SCHAEFFER, W.J., KRETZSCHMAR, H.A., HEAD, M.W., IRONSIDE, J.W., GAMBETTI, P. and CHEN, S.G. (2001). Genetic influence on the structural variations of the abnormal prion protein. Proceedings of the National Academy of Sciences. 97: 10168-10172 PAULI, G. (2005). Tissue safety in view of CJD and variant CJD. Cell and Tissue Banking. 6: 191-200 PEDEN, A.H., HEAD, M.W., RITCHIE, D.L., BELL, J.E. and IRONSIDE, J.W. (2004). Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet. 364: 527-529 PERETZ, D., WILLIAMSON, R.A., KANEKO, K., VERGARA, J., LECLERC, E., SCHMITT-ULMS, G., MEHLHORN, I.R., LEGNAME, G., WORMALD, M.R., RUDD, P.M., DWEK, R.A., BURTON, D.R. and PRUSINER, S.B. (2001). Antibodies inhibit prion propagation and clear cell cultures of prion infecivity. Nature. 412: 739-743 PRUSINER, S.B. (1982). Novel proteinaceous infectious particles cause scrapie. Science. 216: 136-144 PRUSINER, S.B., SCOTT, M.R., DEARMOND, S.J. and COHEN, F.E. (1998). Protein prion biology. Cell. 93: 337-348 - 24 -
Chapitre I – Les ATNC, un problème de Santé Publique RIESNER, D. (2003). Biochemistry and structure of PrPc and PrPsc. British Medical Bulletin. 66: 21-33 RUTALA, W.A. and WEBER, D.J. (2001). Creutzfeldt-Jakob disease: recommendations for disinfection and sterilization. Clin Infect Dis. 32: 1348-56 RUTALA, W.A. and WEBER, D.J. (2004). Reprocessing endoscopes: United States perspective. Journal of Hospital Infection. 56 Suppl 2: S27-39 SABORIO, G.P., PERMANNE, B. and SOTO, C. (2001). Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature. 411: 810-813 SYSTCHENKO, R., MARCHETTI, B., CANARD, J.N., PALAZZO, L., PONCHON, T., REY, J.F. and SAUTEREAU, D. (2000). Guidelines of the French Society of Digestive Endoscopy: recommendations for setting up cleaning and disinfection procedures in gastrointestinal endoscopy. Endoscopy. 32: 807-18 TAYLOR, D.M. (1999). Inactivation of prions by physical and chemical means. Journal of Hospital Infection. 43: 569-576 TAYLOR, D.M. (2000). Inactivation of transmissible degenerative encephalopathy agents: a review. The veterinary Journal. 159: 10-17 TAYLOR, D.M. (2001). Resistance of transmissible spongiform encephalopathy agents to decontamination. Contrib Microbiol. 7: 58-67 WILL, R.G. (2003). Acquired prion disease: iatrogenic CJD, variant CJD, kuru. British Medical Bulletin. 66: 255-265 ZIMMERMAN, K., TURECEK, P.L. and SCHWARZ, H.P. (1999). Genotyping of the prion protein gene at codon 129. Acta Neuropathologica. 97: 355-358 - 25 -
Page 1: N° d’ordre 2006-21 Année 2006 T
Page 5 and 6: SOMMAIRE INTRODUCTION GENERALE CHAP
Page 7: CHAPITRE V: INTERFACE BSA/METAL I.
Page 10 and 11: et quantitativement l’efficacité
Page 12 and 13: Chapitre I - Les ATNC, un Problème
Page 14 and 15: Chapitre I - Les ATNC, un problème
Page 34 and 35: - 26 - Chapitre II - Evaluation du
Page 36 and 37: - 28 - Chapitre II - Evaluation du
Page 38 and 39: Chapitre II - Evaluation du Nettoya
Page 64 and 65: Chapitre III - Efficacité du Netto
Page 82 and 83:
Chapitre III - Efficacité du Netto
Page 84 and 85:
Page 86 and 87:
Page 88 and 89:
Page 90 and 91:
Page 92 and 93:
Page 94 and 95:
Page 96 and 97:
Page 98 and 99:
Page 100 and 101:
Page 102 and 103:
Page 104 and 105:
Page 106 and 107:
- 98 - Chapitre IV - Les Protagonis
Page 108 and 109:
Chapitre IV - Les Protagonistes de
Page 110 and 111:
Page 112 and 113:
Page 114 and 115:
Page 116 and 117:
Page 118 and 119:
Page 120 and 121:
Page 122 and 123:
Page 124 and 125:
Page 126 and 127:
Page 128 and 129:
Page 130 and 131:
Page 132 and 133:
- 124 - Chapitre V - Interface BSA/
Page 134 and 135:
Chapitre V - Interface BSA/métal l
Page 136 and 137:
Chapitre V - Interface BSA/métal L
Page 138 and 139:
Chapitre V - Interface BSA/métal I
Page 140 and 141:
Chapitre V - Interface BSA/métal m
Page 142 and 143:
Page 144 and 145:
Page 146 and 147:
Chapitre V - Interface BSA/métal C
Page 148 and 149:
Chapitre V - Interface BSA/métal
Page 150 and 151:
Chapitre V - Interface BSA/métal t
Page 152 and 153:
Page 154 and 155:
Chapitre V - Interface BSA/métal A
Page 156 and 157:
Chapitre V - Interface BSA/métal (
Page 158 and 159:
Chapitre V - Interface BSA/métal D
Page 160 and 161:
Page 162 and 163:
Page 164 and 165:
Chapitre V - Interface BSA/métal E
Page 166 and 167:
Chapitre V - Interface BSA/métal m
Page 168 and 169:
Chapitre V - Interface BSA/métal F
Page 170 and 171:
Chapitre V - Interface BSA/métal U
Page 172 and 173:
Page 174 and 175:
Chapitre V - Interface BSA/métal (
Page 176 and 177:
Chapitre V - Interface BSA/métal A
Page 178 and 179:
Page 180 and 181:
Chapitre V - Interface BSA/métal P
Page 182 and 183:
Chapitre V - Interface BSA/métal V
Page 184 and 185:
Page 186 and 187:
Page 188 and 189:
Chapitre V - Interface BSA/métal R
Page 190 and 191:
- 182 - Chapitre V - Interface BSA/
Page 192 and 193:
Conclusion Générale résiduelle,
Page 194 and 195:
- 186 -
Page 196 and 197:
Annexe 1 - La Spectroscopie de Phot
Page 198 and 199:
Annexe 1 - La Spectroscopie de Phot
Page 200 and 201:
Annexe 2 - Marquage des protéines
Page 202 and 203:
Annexe 3 - Le Western blot Le princ
Page 204 and 205:
Annexe 3 - Le Western blot Les cond
Page 206 and 207:
- 198 - Annexe 3 - Le Western blot
Page 208 and 209:
Annexe 4 - Les Biais Méthodologiqu
Page 210 and 211:
Annexe 4 - Les Biais Méthodologiqu
Page 212 and 213:
Annexe 5 - Calculs des épaisseurs
Page 214 and 215:
- 206 -
Page 216:
- 208 -
show all

MR thèse 2006-21 - Bibliothèque Ecole Centrale Lyon

Create successful ePaper yourself

Delete template?

Save as template?